Antivirals - GEN - Genetic Engineering and Biotechnology News

Antivirals

Pfizer and Clear Creek Bio to Collaborate on COVID-19 Antiviral Research Program

3d illustration - Virus Attack

Antivirals

An Inhibiting Enzyme Found That Boosts Innate Immune Response

Transparent Glass Bottles at Production Line

Antivirals

Tech Innovation Needed to Boost Capacity and Cut mAb Production Costs

Antivirals

Structural Insights into Viral Budding Unveil Potential Target for Deadly Diseases

Coronavirus 2019-nCoV spreading

Coronavirus

StockWatch: Humanigen Wilts after COVID-19 Antibody Fails NIH Trial

Immuno-oncology

StockWatch: Checkmate Shares Quadruple on Regeneron Buyout

Infectious Diseases

Pfizer to Acquire ReViral for Up to $525M, Expanding RSV Pipeline

Antivirals

Nasal Spray for Prevention/Early Treatment of COVID-19 Works in Mice

coronavirus

Antivirals

COVID-19 Proteases Inhibited by Repurposed FDA-Approved Drugs

Unemployed businesswoman depressed sitting on a path due to company bankrupted while coronavirus spreading situation

Antivirals

Keeping SARS-CoV-2 Reinfections at Bay

Coronavirus

“Game Changer:” After Vaccines, Pfizer Stakes Claim in COVID-19 Drugs, Too

Dengue virus, artwork

Antivirals

Potent Dengue Antiviral Effective against All Known Variants

Antivirals

Pardes Biosciences Advances Oral Antiviral Drug for SARS-CoV-2 Infections

Antivirals

Merck to Seek FDA EUA for COVID-19 Pill after Positive Phase...

Scanning electron micrograph of HIV particles infecting a human T cell. By binding to two unchanging sites on the surface of HIV

Antivirals

Gene Identified in Mice and Monkeys Acts as Natural Antiviral Against...

12 3...9 Page 1 of 9